0 EA
no
show
1   
Ȩ Àå¹Ù±¸´Ï ÁÖ¹®¹è¼ÛÁ¶È¸ ¸¶ÀÌÆäÀÌÁö
   ÇöÀçÀ§Ä¡ : HOME >
Infection and Immunity 4/e
ÆǸŰ¡°Ý  : 35,000¿ø
Àû¸³±Ý  : 1,050Á¡
ÃâÆǻ砠: Academic Press
ÀúÀÚ  : Playfair, Bancroft
¹ßÇàÀÏ  : 2013³â
ÆäÀÌÁö ¼ö  : 400¸é
ISBN  : 9780199609505
¼Ò°³Çϱ⠠:
ÁÖ¹®¼ö·®  :
°³
The infectious organisms| 1 Introduction: parasites, pathogens, and immunity | 2 Viruses | 3 Bacteria | 4 Fungi | 5 Protozoa | 6 Helminths (worms) | 7 Ectoparasites | 8 Prions | 9 Disease: virulence and susceptibility | The immune system | 10 Defence, immunity, the immune system | 11 External defences: entry and exit | 12 Innate immunity | 13 How pathogens escape innate immunity | 14 Disease due to innate immunity | 15 Immunodeficiency I: primary defects of innate immunity | 16 Adaptive immunity: introduction | 17 B cells and antibody | 18 T cells and the MHC | 19 The antibody response | 20 Cell-mediated responses | 21 Regulation of immune responses and memory | 22 How pathogens escape adaptive immunity | 23 Disesase due to adaptive immunity I: hypersenstivity | 24 Disease due to adaptive immunity II: autoimmunity | 25 Immunodeficiency II: primary defects of adaptive immunity | 26 Immunodeficiency III: secondary immunodeficiency and AIDS The host-pathogen balance | 27 Epidemiology | 28 Control of infectious disease: vaccination | 29 Control of infectious disease: chemotherapy | 30 Control of infectious disease: public health measures | 31 Viral and prion disease and immunity | 32 Bacterial disease and immunity | 33 Fungal disease and immunity | 34 Protozoal disease and immunity | 35 Helminth disease and immunity | 36 Ectoparasites and immunity | 37 Emerging and future infectious diseases
{±³Àç »ç¿ë½Ã °­ÀÇ ÀÚ·á ¹®ÀÇ ¹Ù¶ø´Ï´Ù.}
»óÇ°Á¤º¸°í½Ã
Á¦Ç°¸í Infection and Immunity 4/e
ÆǸŰ¡°Ý 35,000¿ø
Á¦Á¶»ç Academic Press
À§ »óÇ°°ú °ü·ÃµÈ »óÇ°ÀÌ ¾ø½À´Ï´Ù.
¹øÈ£ Á¦¸ñ À̸§ º°Á¡ ³¯Â¥
¾ÆÁ÷ ÀÛ¼ºµÈ »óÇ°ÆòÀÌ ¾ø½À´Ï´Ù.
 
¹øÈ£ Á¦¸ñ À̸§ ³¯Â¥ ºñ°í
ÀÛ¼ºµÈ »óÇ°¹®ÀÇ°¡ ¾ø½À´Ï´Ù.
  »óÇ°¹®ÀÇÇϱâ
±¸ÀÔÁ¦Ç°ÀÇ ÀÌ»óÀÌ ÀÖÀ» °æ¿ì
- ±¸ÀÔÈÄ 7ÀÏ À̳»¿¡ µ¿ÀÏÁ¦Ç°À¸·Î ±³È¯ °¡´ÉÇÏ¸ç ¿î¼Ûºñ´Â ÆǸÅÀÚ ºÎ´ãÀÔ´Ï´Ù.
- ´Ù¸¥ Á¦Ç°À¸·Î ±³È¯, ¶Ç´Â ÀÌ»óÀÌ ¾ø´Â Á¦Ç°°ú ÇÔ²² ±³È¯À» ¿øÇÏ½Ç °æ¿ì ±¸¸ÅÀÚ²²¼­ ¿î¼Ûºñ¸¦ ºÎ´ãÇÕ´Ï´Ù.

±¸ÀÔÁ¦Ç°ÀÇ ÀÌ»óÀÌ ÀÖÀ» °æ¿ì (»ö»ó,»çÀÌÁî,´Ù¸¥»óÇ°±³È¯)
- ±¸ÀÔÈÄ 7ÀÏÀ̳» ±³È¯ °¡´ÉÇÏ¸ç ±¸¸ÅÀÚ²²¼­ ¿î¼Ûºñ¸¦ ºÎ´ãÇÕ´Ï´Ù.
(30000¿ø ÀÌ»ó ±¸¸ÅÇϼż­ Åùèºñ¸¦ ¹«»óÀ¸·Î ¹ÞÀ¸¼ÌÀ» °æ¿ì, Ãë¼ÒÇÏ½Ã°Ô µÇ¸é ¿Õº¹ ¿î¼Ûºñ¸¦ ±¸¸ÅÀÚ²²¼­ ºÎ´ãÇÕ´Ï´Ù.)

!! ÁÖÀÇ»çÇ×
ºñ´ÒÆ÷Àå ¹× TagÀÇ Æó±â ¶Ç´Â ÈÑ¼Õ µîÀ¸·Î »óÇ° °¡Ä¡°¡ ¸ê½ÇµÈ °æ¿ì¿¡´Â Á¦ÇÑ.
¹ÝÇ°½Ã¿¡ ÇØ´ç »çÀºÇ°ÀÌ ÀÖÀ» °æ¿ì °°ÀÌ º¸³»ÁÖ¼Å¾ß ÇÕ´Ï´Ù.
°áÁ¦ÈÄ 2~5ÀÏ À̳»¿¡ »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
±¹³» ÃÖ´ëÀÇ ¹°·ù»ç CJÅù踦 ÅëÇÏ¿© ½Å¼ÓÇÏ°í ¾ÈÀüÇÏ°Ô ¹è¼ÛµË´Ï´Ù.
3¸¸¿ø ÀÌ»ó ±¸ÀԽà ¹«·á¹è¼ÛÀÔ´Ï´Ù.
(Á¦ÁÖµµ¸¦ Æ÷ÇÔÇÑ µµ¼­,»ê°£Áö¿ªÀº Ç×°ø·á ¶Ç´Â µµ¼±·á°¡ Ãß°¡µË´Ï´Ù.)
°áÁ¦¹æ¹ýÀº ½Å¿ëÄ«µå, ±¹¹Î/BC(ISP), ¹«ÅëÀåÀÔ±Ý, Àû¸³±ÝÀÌ ÀÖ½À´Ï´Ù.
Á¤»óÀûÀÌÁö ¸øÇÑ °áÁ¦·Î ÀÎÇÑ ÁÖ¹®À¸·Î ÆÇ´ÜµÉ ¶§´Â ÀÓÀÇ·Î ¹è¼ÛÀÌ º¸·ùµÇ°Å³ª,ÁÖ¹®ÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.
ºÐÀÚ»ý¹°ÇÐ ÀÔ¹® Á¦3ÆÇ È¦.. [NEW] 2024/04/17
·¹´ÑÀú 8ÆÇ ¿ÀŸ [NEW] 2024/04/16
·¹´ÑÀú 8ÆÇ p132 2024/04/15
ÇнÀ¹®Á¦ ÇØ´ä 2024/04/14
[´äº¯] ÇнÀ¹®Á¦ ÇØ´ä 2024/04/15
½Ä¹°º´ÇлçÀü 24,000¿ø
Molecular Biotechnology .. 50,000¿ø
Manual of Clinical Micro.. 280,000¿ø
Genomics, Proteomics and.. 60,000¿ø
»ó´ã½Ã°£    ÆòÀÏ 09:30 ~ 18:00 Åä,ÀÏ,°øÈÞÀÏ ÈÞ¹«
»ó´ã ¹× ¹®ÀÇÀüÈ­    02-581-5811~3 |  Æѽº:02-521-6418 (worldscience5811@naver.com)
»óÈ£ : (ÁÖ)¿ùµå»çÀ̾ð½º|¼­¿ïƯº°½Ã ¼­Ãʱ¸ µµ±¸·Î 115, 1Ãþ(¹æ¹èµ¿, ¿ùµåºôµù)
»ç¾÷ÀÚµî·Ï¹øÈ£ : 120-81-64063 (Á¤º¸È®ÀÎ)| Åë½ÅÆǸž÷½Å°í : ¼­¿ï ¼­ÃÊ Á¦1520È£
´ëÇ¥ÀÌ»ç : ¹Ú¼±Áø| °³ÀÎÁ¤º¸ °ü¸®Ã¥ÀÓÀÚ : ¹Ú¼±Áø| °³ÀÎÁ¤º¸ º¸È£±â°£ : ȸ¿øÅ»Åð½Ã
Copyright¨Ï (ÁÖ)¿ùµå»çÀ̾𽺠All rights reserved. Designed by wepas.com